Published in J Cell Physiol on August 01, 2013
Influence of tumour micro-environment heterogeneity on therapeutic response. Nature (2013) 4.78
Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol (2014) 1.71
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation. Nat Cell Biol (2015) 1.61
Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget (2015) 1.21
Multifocal epithelial tumors and field cancerization: stroma as a primary determinant. J Clin Invest (2014) 1.10
Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis. PLoS One (2014) 0.91
Stroma as an Active Player in the Development of the Tumor Microenvironment. Cancer Microenviron (2014) 0.89
Miniaturized pre-clinical cancer models as research and diagnostic tools. Adv Drug Deliv Rev (2013) 0.89
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells. Cancer Immunol Res (2015) 0.89
Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic. J Pathol (2013) 0.86
Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins. BMC Cancer (2014) 0.84
Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures. Med Res Rev (2015) 0.83
Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression. Neoplasia (2014) 0.83
Critical Role of Tumor Microenvironment in Shaping NK Cell Functions: Implication of Hypoxic Stress. Front Immunol (2015) 0.82
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs. Oncotarget (2015) 0.82
Stretching fibroblasts remodels fibronectin and alters cancer cell migration. Sci Rep (2015) 0.81
The role of the tumor stroma in ovarian cancer. Front Oncol (2014) 0.81
The Mycoplasma hyorhinis p37 Protein Rapidly Induces Genes in Fibroblasts Associated with Inflammation and Cancer. PLoS One (2015) 0.81
miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts. Oncotarget (2015) 0.81
Repurposed drug screen identifies cardiac glycosides as inhibitors of TGF-β-induced cancer-associated fibroblast differentiation. Oncotarget (2016) 0.80
Priming cancer cells for drug resistance: role of the fibroblast niche. Front Biol (Beijing) (2014) 0.80
Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. World J Gastroenterol (2015) 0.80
The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition. PLoS One (2014) 0.79
Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget (2015) 0.79
Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment. Neoplasia (2015) 0.79
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients. J Transl Med (2014) 0.79
Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells. Int J Mol Med (2014) 0.79
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity. Connect Tissue Res (2015) 0.78
TGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling Mechanisms. PLoS One (2015) 0.77
Dkk-1 and IL-7 in plasma of patients with multiple myeloma prevent differentiation of mesenchymal stem cells into osteoblasts. Am J Blood Res (2014) 0.77
Validation of COL11A1/procollagen 11A1 expression in TGF-β1-activated immortalised human mesenchymal cells and in stromal cells of human colon adenocarcinoma. BMC Cancer (2014) 0.77
Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro. Cancer Invest (2013) 0.77
Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients. J Exp Clin Cancer Res (2016) 0.77
Modulation of type II TGF-β receptor degradation by integrin-linked kinase. J Invest Dermatol (2014) 0.77
The human papillomavirus E7 oncoprotein as a regulator of transcription. Virus Res (2016) 0.76
Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc Natl Acad Sci U S A (2016) 0.76
Podoplanin expression in the cyst wall correlates with the progression of intraductal papillary mucinous neoplasm. Virchows Arch (2014) 0.76
Disruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease. J Cell Physiol (2014) 0.76
Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment. Oncol Lett (2016) 0.76
Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Res (2017) 0.75
Loss of mesenchymal bone morphogenetic protein signaling leads to development of reactive stroma and initiation of the gastric neoplastic cascade. Sci Rep (2016) 0.75
Stromal contributions to the carcinogenic process. Mol Carcinog (2016) 0.75
Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells. J Exp Clin Cancer Res (2016) 0.75
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis. Cancers (Basel) (2015) 0.75
Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells. Int J Biol Sci (2017) 0.75
The inflammatory/cancer-related IL-6/STAT3/NF-κB positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget (2016) 0.75
Relationship between ultrasound elastography and myofibroblast distribution in breast cancer and its clinical significance. Sci Rep (2016) 0.75
An in vivo screening system to identify tumorigenic genes. Oncogene (2016) 0.75
Effect of novobiocin on the viability of human gingival fibroblasts (HGF-1). BMC Pharmacol Toxicol (2014) 0.75
Snail suppresses cellular senescence and promotes fibroblast-led cancer cell invasion. FEBS Open Bio (2017) 0.75
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J Pathol (2017) 0.75
Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth. Oncogenesis (2017) 0.75
Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. J Exp Med (2017) 0.75
Epithelial-to-mesenchymal transition transcription factors in cancer-associated fibroblasts. Mol Oncol (2017) 0.75
Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A (2010) 3.03
Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol (2009) 2.25
Carcinoma-associated fibroblasts are a promising therapeutic target. Cancers (Basel) (2013) 1.01
Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr (2012) 0.94
Experimental generation of carcinoma-associated fibroblasts (CAFs) from human mammary fibroblasts. J Vis Exp (2011) 0.79
Transforming growth factor-β: guardian of catabolic metabolism in carcinoma-associated fibroblasts. Cell Cycle (2012) 0.75